IQVIA Q3 revenue $3,896M, Adj EPS $2.84 (+14.1%); FY24 guidance cut on trial delays

IQVIA HOLDINGS INC.

2024-Q3 EPS reported $5.08 revenue$11,447,000,000

Q3 revenue $3,896M (+4.3% YoY); GAAP EPS $1.55; Adj EPS $2.84 (+14.1%).
R&D Solutions backlog $31.1B (+8% YoY); book-to-bill 1.22x TTM (excl. cancellation).
TAS revenue $1,554M (+8.6% YoY), accelerating from prior quarters.
FY24 guidance lowered: rev $15,350-15,400M; Adj EPS $11.10-11.20 due to two mega trial delays.
Operating cash flow YTD $1,831M (+31% YoY); FCF $1,393M (+49% YoY); $200M share buyback in Q3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.